Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Zika Virus Infection, February 2024 Free Subscription Abstracts Retrieve all available abstracts of the following 65 articles: HTML format

Single Articles

1. VICTORIO CBL, Novera W, Ganasarajah A, Ong J, et al
   Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells.
   J Transl Med. 2024;22:126.
   PubMed    
   Abstract available
   
   

2. LEBEAU G, Hoareau M, Riviere S, El Safadi D, et al
   Cell cycle and mitosis progression during ZIKA virus infection: The viral non-structural protein NS5 as a master regulator of the APC/cyclosome?
   Biochimie. 2024 Jan 31:S0300-9084(24)00034-8. doi: 10.1016/j.biochi.2024.
   PubMed    
   Abstract available
   
   

3. MAAMAR MH, Ehrhardt M, Tabharit L
   A nonstandard finite difference scheme for a time-fractional model of Zika virus transmission.
   Math Biosci Eng. 2024;21:924-962.
   PubMed    
   Abstract available
   
   

4. DOS SANTOS AS, da Costa MG, Faustino AM, de Almeida W, et al
   Neuroinflammation, blood-brain barrier dysfunction, hippocampal atrophy and delayed neurodevelopment: Contributions for a rat model of congenital Zika syndrome.
   Exp Neurol. 2024 Jan 30:114699. doi: 10.1016/j.expneurol.2024.114699.
   PubMed    
   Abstract available
   
   

5. BURKE JM, Ratnayake OC, Watkins JM, Perera R, et al
   G3BP1-dependent condensation of translationally inactive viral RNAs antagonizes infection.
   Sci Adv. 2024;10:eadk8152.
   PubMed    
   Abstract available
   
   

6. MOORE KM, Pelletier AN, Lapp S, Metz A, et al
   Single cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells.
   bioRxiv. 2024 Jan 21:2024.01.19.576293. doi: 10.1101/2024.01.19.576293.
   PubMed    
   Abstract available
   
   

7. ABU AEI, Becker M, Accoti A, Sylla M, et al
   Low humidity enhances Zika virus infection and dissemination in Aedes aegypti mosquitoes.
   bioRxiv. 2024 Jan 18:2024.01.17.576075. doi: 10.1101/2024.01.17.576075.
   PubMed    
   Abstract available
   
   

8. MORALES SV, Coelho GM, Ricciardi-Jorge T, Dorl GG, et al
   Development of a quantitative NS1 antigen enzyme-linked immunosorbent assay (ELISA) for Zika virus detection using a novel virus-specific mAb.
   Sci Rep. 2024;14:2544.
   PubMed    
   Abstract available
   
   

9. HUANG GG, Wang HY, Wang XH, Yang T, et al
   Atranorin inhibits Zika virus infection in human glioblastoma cell line SNB-19 via targeting Zika virus envelope protein.
   Phytomedicine. 2024;125:155343.
   PubMed    
   Abstract available
   
   

10. SAVINO DF, Silva JV, da Silva Santos S, Lourenco FR, et al
    How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease?
    J Mol Model. 2024;30:54.
    PubMed    
    Abstract available
    
    

11. LI M, Kandul NP, Sun R, Yang T, et al
    Targeting sex determination to suppress mosquito populations.
    Elife. 2024;12:RP90199.
    PubMed    
    Abstract available
    
    

12. CALADO AM, Seixas F, Dos Anjos Pires M
    Virus as Teratogenic Agents.
    Methods Mol Biol. 2024;2753:105-142.
    PubMed    
    Abstract available
    
    

13. VAZ LBA, Amparo TR, Reis ACC, de Mello Silva B, et al
    Identification, characterization and quantification of xanthones from Fridericia formosa leaves extract with antiviral activity.
    Sci Rep. 2024;14:2258.
    PubMed    
    Abstract available
    
    

14. OBLOZA M, Milewska A, Botwina P, Szczepanski A, et al
    Curcumin-Poly(sodium 4-styrenesulfonate) Conjugates as Potent Zika Virus Entry Inhibitors.
    ACS Appl Mater Interfaces. 2024 Jan 26. doi: 10.1021/acsami.3c13893.
    PubMed    
    Abstract available
    
    

15. ZHANG W, Cui L, Wang Y, Xie Z, et al
    An Integrated ddPCR Lab-on-a-Disc Device for Rapid Screening of Infectious Diseases.
    Biosensors (Basel). 2023;14:2.
    PubMed    
    Abstract available
    
    

16. DENNINGTON NL, Grossman MK, Ware-Gilmore F, Teeple JL, et al
    Phenotypic adaptation to temperature in the mosquito vector, Aedes aegypti.
    Glob Chang Biol. 2024;30:e17041.
    PubMed    
    Abstract available
    
    

17. ESTEVEZ-CASTRO CF, Rodrigues MF, Babarit A, Ferreira FV, et al
    Neofunctionalization driven by positive selection led to the retention of the loqs2 gene encoding an Aedes specific dsRNA binding protein.
    BMC Biol. 2024;22:14.
    PubMed    
    Abstract available
    
    

18. ZHU H, Wang D, Ye Z, Huang L, et al
    The temporal association of CapZ with early endosomes regulates endosomal trafficking and viral entry into host cells.
    BMC Biol. 2024;22:12.
    PubMed    
    Abstract available
    
    

19. ANDERSON MAE, Gonzalez E, Edgington MP, Ang JXD, et al
    A multiplexed, confinable CRISPR/Cas9 gene drive can propagate in caged Aedes aegypti populations.
    Nat Commun. 2024;15:729.
    PubMed    
    Abstract available
    
    

20. CAMPOS RK, Liang Y, Azar SR, Ly J, et al
    CD8 (+) T cell response promotes viral clearance and reduces chances of severe testicular damage in mouse models of long-term Zika virus infection of the testes.
    bioRxiv. 2024 Jan 23:2024.01.22.575592. doi: 10.1101/2024.01.22.575592.
    PubMed    
    Abstract available
    
    

21. DOBHAL K, Garg R, Singh A, Semwal A, et al
    Insight into the Natural Biomolecules (BMs): Promising Candidates as Zika Virus Inhibitors.
    Infect Disord Drug Targets. 2024.
    PubMed    
    Abstract available
    
    

22. CAETANO CCS, Azamor T, Meyer NM, Onwubueke C, et al
    Mechanistic insights into bone remodelling dysregulation by human viral pathogens.
    Nat Microbiol. 2024;9:322-335.
    PubMed    
    Abstract available
    
    

23. MCBROOME J, de Bernardi Schneider A, Roemer C, Wolfinger MT, et al
    A framework for automated scalable designation of viral pathogen lineages from genomic data.
    Nat Microbiol. 2024;9:550-560.
    PubMed    
    Abstract available
    
    

24. BALINT E, Feng E, Giles EC, Ritchie TM, et al
    Bystander activated CD8(+) T cells mediate neuropathology during viral infection via antigen-independent cytotoxicity.
    Nat Commun. 2024;15:896.
    PubMed    
    Abstract available
    
    

25. PIVA-AMARAL R, Augusto Pires de Souza G, Carlos Vilela Vieira Junior J, Froes Goulart de Castro R, et al
    Bovine serum albumin nanoparticles containing Poly (I:C) can enhance the neutralizing antibody response induced by envelope protein of Orthoflavivirus zikaense.
    Int Immunopharmacol. 2024;128:111523.
    PubMed    
    Abstract available
    
    

26. RADER JA, Serrato-Capuchina A, Anspach T, Matute DR, et al
    The spread of Aedes albopictus (Diptera: Culicidae) in the islands of Sao Tome and Principe.
    Acta Trop. 2024;251:107106.
    PubMed    
    Abstract available
    
    

27. MATUTE DR, Cooper BS
    Aedes albopictus is present in the lowlands of southern Zambia.
    Acta Trop. 2024;251:107115.
    PubMed    
    Abstract available
    
    

28. DHANUSHKUMAR T, Selvam PK, M E S, Vasudevan K, et al
    Rational design of a multivalent vaccine targeting arthropod-borne viruses using reverse vaccinology strategies.
    Int J Biol Macromol. 2024;258.
    PubMed    
    Abstract available
    
    

29. LIU BM, Mulkey SB, Campos JM, DeBiasi RL, et al
    Laboratory diagnosis of CNS infections in children due to emerging and re-emerging neurotropic viruses.
    Pediatr Res. 2024;95:543-550.
    PubMed    
    Abstract available
    
    

30. TALAGA S, Compin A, Azemar F, Leroy C, et al
    Urbanization and Water Containers Influence the Mosquito Community with Consequences for Aedes aegypti.
    Neotrop Entomol. 2024;53:162-170.
    PubMed    
    Abstract available
    
    

31. MUKHOPADHYAY K, Sengupta M, Misra SC, Majee K, et al
    Trends in emerging vector-borne viral infections and their outcome in children over two decades.
    Pediatr Res. 2024;95:464-479.
    PubMed    
    Abstract available
    
    

32. KAURA T, Sarkar S, Sharma V, Mewara A, et al
    Molecular detection of dengue and chikungunya viruses in surveillance of wild-caught Aedes mosquitoes in Punjab, North India.
    Trans R Soc Trop Med Hyg. 2024;118:95-101.
    PubMed    
    Abstract available
    
    

33. ROCHLANI S, Bhatia M, Rathod S, Choudhari P, et al
    Exploration of limonoids for their broad spectrum antiviral potential via DFT, molecular docking and molecular dynamics simulation approach.
    Nat Prod Res. 2024;38:891-896.
    PubMed    
    Abstract available
    
    

34. KEY AP, Powell SL, Cavalcante J, Frizzo A, et al
    Auditory Neural Responses and Communicative Functioning in Children With Microcephaly Related to Congenital Zika Syndrome.
    Ear Hear. 2024 Feb 6. doi: 10.1097/AUD.0000000000001477.
    PubMed    
    Abstract available
    
    

35. TEIXEIRA FME, Oliveira LM, Branco ACCC, Alberca RW, et al
    Corrigendum: Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants.
    Front Immunol. 2024;15:1376059.
    PubMed    
    Abstract available
    
    

36. TEIXEIRA FME, Oliveira LM, Branco ACCC, Alberca RW, et al
    Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants.
    Front Immunol. 2024;15:1307546.
    PubMed    
    Abstract available
    
    

37. KIM IJ, Tighe MP, Lanthier PA, Clark MJ, et al
    Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice.
    NPJ Vaccines. 2024;9:32.
    PubMed    
    Abstract available
    
    

38. EDILLO F, Ymbong RR, Navarro AO, Cabahug MM, et al
    Detecting the impacts of humidity, rainfall, temperature, and season on chikungunya, dengue and Zika viruses in Aedes albopictus mosquitoes from selected sites in Cebu city, Philippines.
    Virol J. 2024;21:42.
    PubMed    
    Abstract available
    
    

39. HAKAMI MA
    An immunoinformatics and structural vaccinology approach to design a novel and potent multi-epitope base vaccine targeting Zika virus.
    BMC Chem. 2024;18:31.
    PubMed    
    Abstract available
    
    

40. MAHMOUD A, Pomar L, Lambert V, Picone O, et al
    Prenatal and Postnatal Ocular Abnormalities Following Congenital Zika Virus Infections: A Systematic Review.
    Ocul Immunol Inflamm. 2024 Feb 13:1-11. doi: 10.1080/09273948.2024.2314086.
    PubMed    
    Abstract available
    
    

41. SINGH T, Miller IG, Venkatayogi S, Webster H, et al
    Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques.
    mBio. 2024 Feb 13:e0316023. doi: 10.1128/mbio.03160.
    PubMed    
    Abstract available
    
    

42. PANT S, Jena NR
    Binding of Nucleotide Inhibitors to the NS5 RdRp of the ZIKA Virus in the Replication Initiation State.
    Curr Med Chem. 2024 Feb 12. doi: 10.2174/0109298673259914231213052438.
    PubMed    
    Abstract available
    
    

43. ALARCON-ELBAL PM, Suarez-Balseiro C, De Souza C, Soriano-Lopez A, et al
    History of research on Aedes albopictus (Diptera: Culicidae) in Europe: approaching the world's most invasive mosquito species from a bibliometric perspective.
    Parasitol Res. 2024;123:130.
    PubMed    
    Abstract available
    
    

44. KHARWADKAR S, Herath N
    Clinical manifestations of dengue, Zika and chikungunya in the Pacific Islands: A systematic review and meta-analysis.
    Rev Med Virol. 2024;34:e2521.
    PubMed    
    Abstract available
    
    

45. LI Q, Zhang J, Deng Q, Liao C, et al
    A Divalent Chikungunya and Zika Nanovaccine with Thermostable Self-assembly Multivalent Scaffold LS-SUMO.
    Adv Healthc Mater. 2024 Feb 10:e2303619. doi: 10.1002/adhm.202303619.
    PubMed    
    Abstract available
    
    

46. KATZELNICK LC, Quentin E, Colston S, Ha TA, et al
    Increasing transmission of dengue virus across ecologically diverse regions of Ecuador and associated risk factors.
    PLoS Negl Trop Dis. 2024;18:e0011408.
    PubMed    
    Abstract available
    
    

47. CONTRERAS M, Stuart JB, Levoir LM, Belmont L, et al
    Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies.
    mBio. 2024;15:e0304823.
    PubMed    
    Abstract available
    
    

48. KWON T
    Utilizing non-human primate models to combat recent COVID-19/SARS-CoV-2 and viral infectious disease outbreaks.
    J Med Primatol. 2024;53:e12689.
    PubMed    
    Abstract available
    
    

49. MENSAH IK, Norvil AB, He M, Lendy E, et al
    Development of a sensitive microplate assay for characterizing RNA methyltransferase activity: Implications for epitranscriptomics and drug development.
    J Biol Chem. 2023;299:105257.
    PubMed    
    Abstract available
    
    

50. ELLIOTT KC, Mattapallil JJ
    Zika Virus-A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis.
    Pathogens. 2024;13:177.
    PubMed    
    Abstract available
    
    

51. MULKEY SB, Corn E, Williams ME, Peyton C, et al
    Neurodevelopmental Outcomes of Normocephalic Colombian Children with Antenatal Zika Virus Exposure at School Entry.
    Pathogens. 2024;13:170.
    PubMed    
    Abstract available
    
    

52. AHMED S, Sultana S, Kundu S, Alam SS, et al
    Global Prevalence of Zika and Chikungunya Coinfection: A Systematic Review and Meta-Analysis.
    Diseases. 2024;12:31.
    PubMed    
    Abstract available
    
    

53. SOSA-ACOSTA P, Quinones-Vega M, Guedes JS, Rocha D, et al
    Multiomics Approach Reveals Serum Biomarker Candidates for Congenital Zika Syndrome.
    J Proteome Res. 2024 Feb 23. doi: 10.1021/acs.jproteome.3c00677.
    PubMed    
    Abstract available
    
    

54. WONG JCC, Tay M, Hapuarachchi HC, Lee B, et al
    Case report: Zika surveillance complemented with wastewater and mosquito testing.
    EBioMedicine. 2024;101:105020.
    PubMed    
    Abstract available
    
    

55. ESPADA CE, da Rocha EL, Ricciardi-Jorge T, Dos Santos AA, et al
    ISG15/USP18/STAT2 is a molecular hub regulating IFN I-mediated control of Dengue and Zika virus replication.
    Front Immunol. 2024;15:1331731.
    PubMed    
    Abstract available
    
    

56. TIPO J, Gottipati K, Choi KH
    High-resolution RNA tertiary structures in Zika virus stem-loop A for the development of inhibitory small molecules.
    RNA. 2024 Feb 21:rna.079796.123. doi: 10.1261/rna.079796.
    PubMed    
    Abstract available
    
    

57. KIM IJ, Gonzalez O, Tighe MP, Lanthier PA, et al
    Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets.
    NPJ Vaccines. 2024;9:35.
    PubMed    
    Abstract available
    
    

58. LI M, Zhou Y, Cheng J, Wang Y, et al
    Response of the mosquito immune system and symbiotic bacteria to pathogen infection.
    Parasit Vectors. 2024;17:69.
    PubMed    
    Abstract available
    
    

59. MIRZA AH, Bram Y, Schwartz RE, Jaffrey SR, et al
    SCARPET: site-specific quantification of methylated and nonmethylated adenosines reveals m(6)A stoichiometry.
    RNA. 2024;30:308-324.
    PubMed    
    Abstract available
    
    

60. YUAN H, Zou JH, Luo Y, Zhang J, et al
    Cellular nuclear-localized U2AF2 protein is hijacked by the flavivirus 3'UTR for viral replication complex formation and RNA synthesis.
    Vet Microbiol. 2024;290:109977.
    PubMed    
    Abstract available
    
    

61. WILLIAMS PL, Karalius B, Patel K, Aschengrau A, et al
    Fetal growth assessed via ultrasound in relation to maternal HIV infection status and antiretroviral regimens.
    AIDS. 2023 Nov 22. doi: 10.1097/QAD.0000000000003796.
    PubMed    
    Abstract available
    
    

62. EARNEST JT, Ciau-Carillo KJ, Kirstein OD, Che-Mendoza A, et al
    Evidence of Ongoing Transmission of Zika Virus in Merida, Mexico.
    Am J Trop Med Hyg. 2024 Feb 20:tpmd230533. doi: 10.4269/ajtmh.23-0533.
    PubMed    
    Abstract available
    
    

63. LI Y, Li Z, Zou H, Zhou P, et al
    A conserved methyltransferase active site residue of Zika virus NS5 is required for the restriction of STING activation and interferon expression.
    J Gen Virol. 2024;105.
    PubMed    
    Abstract available
    
    

64. KITRO A, Imad HA, Pisutsan P, Matsee W, et al
    Seroprevalence of dengue, Japanese encephalitis, and Zika among long-term expatriates in Thailand.
    J Travel Med. 2024 Feb 9:taae022. doi: 10.1093.
    PubMed    
    Abstract available
    
    

65. CHEN X, Li R-T, Chen R-Y, Shi P-D, et al
    The subgenomic flaviviral RNA suppresses RNA interference through competing with siRNAs for binding RISC components.
    J Virol. 2024;98:e0195423.
    PubMed    
    Abstract available